International Clinical Trial: A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants

Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07777133) titled 'A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants' on Aug. 18.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Bristol-Myers Squibb

Condition: Healthy Female Participants

Intervention: Drug: Navlimetostat

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: September 16, 2026

Target Sample Size: 6

Countries of Recruitment: United States Neth...